Carenity Publications
More than 50 publications and research posters based on Carenity studies
The patients’ perspective on botulinum neurotoxin A treatment: results of a multinational survey for patients with spasticity.
Presented at TOXINS 2019 Collaborator: Ipsen Authors: Bahroo L, Patel A, Wein [...]
Burden of spasticity among patients and caregivers: results of a multinational survey
Presented at TOXINS 2019 Collaborator: Ipsen Authors: Patel A, Wein T, Bahroo [...]
What are the most valued patient outcomes regarding medical care for French patients with heart failure? Results from an online patient community
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 Collaborator: [...]
Fewer injections of botulinum toxin type A for treatment of spasticity are perceived as beneficial by both patients and caregivers.
Presented at TOXINS 2019 Collaborator: Ipsen Authors: Wein T, Patel A, Bahroo [...]
What are the most valued patient outcomes regarding medical care for French patients with obesity? Results from an online patient community
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 Collaborator: [...]
Dramatic improvement in treatment acceptance observed in patients with Multiple Sclerosis switching treatment: a real-world study
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 Collaborator: [...]
MS patients’ perception of the effects of PR-fampridine on walking disorders and daily life: results from an observational study conducted via an online community
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 Collaborator: [...]
Walking disorders in MS: how do they impact patients’ quality of life? Results from an observational study conducted via an online patient community
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 Collaborator: [...]
What are the most valued patient outcomes regarding medical care for French patients with type 1 diabetes? Results from an online patient community
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 [...]
-
-
-
Biologics and Biosimilars Barometer
Country: France, Germany, Italy, Spain, UK
Date: 2017, 2018
Respondents: 800
